NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 109 filers reported holding NEVRO CORP in Q3 2015. The put-call ratio across all filers is 0.37 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $408,000 | -10.5% | 10,500 | +31.2% | 0.03% | +24.0% |
| Q3 2018 | $456,000 | -69.4% | 8,000 | -60.0% | 0.02% | -60.3% |
| Q2 2017 | $1,489,000 | +76.2% | 20,000 | +72.0% | 0.06% | +57.5% |
| Q4 2016 | $845,000 | -94.1% | 11,630 | -94.0% | 0.04% | -93.2% |
| Q2 2016 | $14,322,000 | +133.0% | 194,170 | +77.7% | 0.59% | +116.6% |
| Q1 2016 | $6,147,000 | -37.1% | 109,270 | -39.9% | 0.27% | +36.2% |
| Q2 2015 | $9,776,000 | – | 181,886 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,446,333 | $82,441,000 | 4.44% |
| Asymmetry Capital Management, L.P. | 31,379 | $1,789,000 | 1.65% |
| TIRSCHWELL & LOEWY INC | 194,470 | $11,085,000 | 1.38% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 673,480 | $38,388,000 | 1.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 525,040 | $29,927,000 | 1.07% |
| Orbimed Advisors | 1,357,691 | $77,388,000 | 0.93% |
| Sio Capital Management, LLC | 45,091 | $2,570,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 60,000 | $3,420,000 | 0.72% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 159,800 | $9,109,000 | 0.62% |
| Endurant Capital Management LP | 24,171 | $1,378,000 | 0.61% |